One recent analysis found that, over the course of three years, people taking semaglutide (the compound in Ozempic and the weight loss drug Wegovy) were about 40 to 70 percent less likely to be ...

SaveHealth provides an overview of Alzheimer's disease, including treatment and coping mechanisms for those with the disease and caregivers.

These boards are cropping up around the US as neurologists acclimate to a new class of drugs, but not everyone agrees such ...

Researchers from the Genome Center have successfully applied advanced artificial intelligence (AI) genetics models to Parkinson's disease. Researchers identified genetic factors in progression and ...

LATE-NC diagnostic criteria improve differentiation from Alzheimer's, addressing challenges in memory-loss syndromes and ...

Xenon is one of the six noble gases. Its name derives from the Greek word for “strange”. In medicine, it has been used as an ...

We now have two FDA-approved disease-modifying treatments for Alzheimer's disease, and hundreds of clinical trials are ...

Early research suggests GLP-1 drugs could prevent or treat Alzheimer's Disease. Results from a big clinical trial could soon ...

Vigil Neuroscience reported a strong safety profile and 50% sTREM2 reduction in an early-stage trial for VG-3927, potentially ...

As demand for weight-loss injections sold under brand names such as Ozempic and Wegovy continues to soar, a study has ...

People who are newly diagnosed with Alzheimer’s and their caregivers need more support in navigating the healthcare system.

Last year was a productive and exciting year for Alzheimer’s and dementia research. There were significant advancements in early detection, treatment, and risk management. Here are three significant d ...